The occurrence of antibodies giving hemolysis inhibition (HLI) but not hemagglutination inhibition (HI) was examined in human convalescent and rabbit hyperimmune sera. HI antibodies, which through their interaction with hemagglutinin components display HLI activity, were removed by absorption with Tween 80-ether (TE)-treated measles virus material. This absorption did not change the titer of non-HI HLI antibodies. After removal of HI antibodies from 16 late measles convalescent sera and three batches of gamma globulin, HLI antibody titers showed a two-to eightfold reduction. The titers of neutralizing antibodies were reduced from 1/4 to 1/20 of the original titers. There was a good correlation between the titers of neutralizing and HLI antibodies both in sera from which HI antibodies had been removed by absorption and in sera spontaneously showing markedly higher HLI than HI antibody titers. HLI antibodies with these characteristics could be identified in HI tests when whole virus instead of TE-treated material was used an antigen and anti-antiserum was added to the tests. In contrast to the situation in human sera, antibodies remaining after removal of HI antibodies from rabbit hyperimmune sera against purified virus particles were detectable in neutralization and HLI tests only in the presence of anti-antiserum. However, virus particles from which the major fraction of all envelope projections had been removed by treatment with 0.004% trypsin induced the production of non-HI HLI antibodies active also in the absence of anti-antiserum. TE and formalin treatment destroyed the hemolytic activity of virus preparations and also their capacity to induce a production of non-HI HLI antibodies.
In a study of the occurrence of antibodies against different structural components of measles virus in late measles convalescent sera from healthy individuals and from patients with subacute sclerosing panencephalitis and multiple sclerosis, a few samples were encountered in which hemolysis-inhibiting (HLI) antibodies were present in much higher titers than hemagglutination-inhibiting (HI) antibodies (11, 19) . Analysis of a larger number of samples from multiple sclerosis patients and controls revealed the occurrence of sera displaying this kind of preferential HLI antibody response in about 10% of the population (18) . These findings have been interpreted to signify the presence of one or more antigenic components separate from the hemagglutinin in the virus envelope. Since antibodies against this additional envelope component cause an inhibition of virus-specific hemolysis, it will be referred to in this paper as hemolysin, a designation used as an operational term.
Assessment of HLI-specific antibodies can readily be made when these occur in excess over HI antibodies. However, since HI antibodies by their reaction with hemagglutinin indirectly cause an inhibition of hemolysis, the titer of antibodies reacting directly with the hemolysin can not be measured in the presence of these antibodies. A technique is described here for a separate identification of HLI antibodies. It has not been possible to isolate the hemolysin component of the virus and to use this as a specific antigen in immunological test systems. Instead, the technique employed is based on a selective removal of HI antibodies by absorption with hemagglutinin preparations not containing any hemolysin. The occurrence of HLI antibodies in human sera and rabbit hyperimmune sera against different virus products will be described. A special emphasis is put on the analysis of the occurrence of antibodies against different virus envelope components in rabbit hyperimmune sera against products of the kinds previously used as inactivated measles vaccines.
MATERIAL AND METHODS
Virus and cell cultures. Two different strains of measles virus were used for preparation of antigen material. These were the diluted-passage variant of the Edmonston strain (17) and the LEC strain. The latter strain was originally isolated from a case of subacute sclerosing panencephalitis (1) and was kindly provided by Hilary Koprowski, the Wistar Institute, Philadelphia. In some experiments the Montana strain of Newcastle disease virus was used. All virus materials were prepared in mycoplasma-free Vero cells maintained on Eagle minimal essential medium containing 2% fetal calf serum.
Sera. Late measles convalescent sera (collected 4 to 20 years after recovery from regular measles infections) were obtained from the Virus Department of the National Bacteriological Laboratorium, Stockholm. In addition, serum samples selected from the material included in previous studies on the occurrence of different measles virus antibodies in multiple sclerosis patients and controls (18) were used.
Rabbit hyperimmune sera were prepared by injection of 4 ml of antigen mixed with Freund complete adjuvant intramuscularly followed by an intravenous booster 5 weeks later. The animals were exsanguinated 1 week after the booster.
Serological tests. The techniques for neutralization tests in the absence and presence of antiantiserum, HLI, HI, and complement fixation tests with purified nucleocapsids were previously described in detail (11) . The diluted-passage variant of the Edmonston strain was used in neutralization tests and LEC virus material was used as antigen in other serological tests. HLI tests were performed both in the absence and presence of sheep anti-human or antirabbit sera (obtained from the Department of Immunology, the National Bacteriological Laboratorium, Stockholm). Serial twofold dilutions of serum in 0.2 ml were prepared, whereafter 0.1 ml of antigen was added per dilution. After incubation for 1 h at room temperature, 0.1 ml of anti-human or anti-rabbit serum diluted 1:10 was added and the mixtures were incubated for another hour before addition of the erythrocyte suspension. HI tests were carried out with two different antigen preparations, purified wholevirus particles (12) and Tween-ether (TE)-treated virus material (7) . Tests with the different antigen preparations were carried out both in the absence and presence of sheep anti-human or anti-rabbit sera. After preparation of serial twofold dilutions of serum in 0.05 ml, 0.025 ml of properly diluted antigen was added. After incubation for 1 h at room temperature, 0.025 ml of anti-human or anti-rabbit serum diluted 1:10 was added. The erythrocyte suspension was added after still another hour of incubation at room temperature.
HI antibody consumption (HIC) tests were used for identification of incomplete hemagglutinin. Serial twofold dilutions of material. in 0.05 ml were mixed with 0.025 ml containing 2 HI units of a rabbit hyperimmune serum against whole measles virus. After incubation for 1 h at room temperature, 0.025 ml containing 2 hemagglutinating units of TE-treated measles virus material was added to the mixture, whereafter the samples were incubated for another hour at room temperature. Green monkey (Cercopitecus aethiops) erythrocytes (0.05 ml) were then added and the cells were allowed to settle at 37 C. The highest dilution of test samples absorbing HI antibodies, i.e., the last well showing maximal or clear-cut partial agglutination, was considered to contain 1 HIC unit.
Preparation of hemagglutinin devoid of hemolytic activity. Three different procedures were used to prepare antigen material with these properties from concentrated extracellular material. These were (i) TE treatment (7), (ii) Triton X-100 treatment of purified whole-virus material followed by zonal centrifugation in sucrose gradients for preparation of small particle hemagglutinin (12; the detergent in this publication was used under a different trade name, Cutscum), and (iii) Triton X-100 treatment followed by anion exchange chromatography on diethylaminoethyl Sephadex A-25. The major population of small particle hemagglutinin which eluted at 0.25 M NaCl (Norrby, unpublished data) was collected.
Absorption of sera. The procedure used has been described previously (16) . Sera were absorbed with antigen in an amount corresponding to at least four times that calculated from HI tests to be required for binding of all HI antibodies. The mixtures were incubated for 1 h at room temperature and 4 C overnight. After centrifugation at 81,000 x g (35,000 rpm, rotor 40, Spinco Division, Beckman Instruments Inc.) for 2 h the supernatant was collected; if needed, absorptions were repeated. Hemagglutination tests were carried out to determine the amount of hemagglutinin possibly remaining in the mixtures. Excess hemagglutinin was removed by absorption with green monkey erythrocytes.
Electron microscopy. Virus material was added to carbon-coated grids. After incubation for 1 min at room temperature, the grids were washed by dropwise addition of 4% sodium tungstosilicate solution in distilled water. Excess fluid was then removed by a filter paper and the specimens were dried in the air. Thereafter they were examined in a Philips EM 200 electron microscope at a primary magnification of 45,000 to 50,000.
RESULTS
Demonstration of HLI antibodies in human sera after selective removal of HI antibodies. Absorption experiments were carried out with three different preparations of hemagglutinin devoid of hemolytic activity (see above). Since it was possible that these preparations might contain hemolysin separate from hemagglutinin, a situation precluding any expression of the biological activity of the hemolysin, preliminary experiments were carried out with sera selected to contain HLI antibodies in marked excess over HI antibodies. It was found that repeated absorptions with large quantities of TE-treated antigen did not change the HLI antibody titer of this type of sera, whereas, with some preparations of the two other types of purified hemagglutinin, a two-to fourfold reduction in the HLI antibody titer occasionally was encountered. TE-treated material was therefore chosen for further absorption experiments.
Sixteen late measles convalescent sera and three batches of gamma globulin were absorbed with TE-treated antigen until all HI antibodies had been removed. The neutralizing and HLI antibody activity of unabsorbed and absorbed samples were tested in parallel, and some representative results are summarized in Table 1 . The titer of HLI antibodies remained unchanged or was only slightly reduced by the absorption with TE antigen. All samples except one retained capacity to neutralize measles virus after removal of all detectable HI antibodies. However, the neutralization titers after absorption was 4 to 20 times lower than that of unabsorbed samples. The effect of addition of anti-human serum on the neutralizing activity of sera absorbed with TE-treated antigen was analyzed (data not shown) since it was experienced previously (11) that HLI antibodies appeared to be more prone to show an enhanced neutralization under these conditions than HI antibodies. However, only a twofold and in a few cases a fourfold increase in titers was recorded.
A comparison was made between the neutralization and HLI antibody titers of human sera spontaneously displaying high titers of HLI antibodies in the presence of only low titers of HI antibodies encountered in a previous study (18) , and of the above mentioned human sera from which HI antibodies had been removed by absorption with TE antigen (Table 1) . A correlation was found between the titers of HLI and neutralizing antibodies in both groups of sera (Fig. 1) . The effect of anti-human serum on the HLI and HI activity of antibodies remaining after absorption with TE antigen was also studied ( Table 2 and HLI antibodies in sera (0) with high antibodies in the presence of low titer I included in a previous study (20) and in similar characteristics after removal of i by absorption with TE-treated antigen.
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TE-treated purified whole virus products; E, formalin-treated whole virus-products. Table 4 . Absorption of antisera against purified virus particles with TE-treated virus antigen and, in addition, uninfected Vero cells did not remove antibodies detectable in HLI tests and whole-virus HI tests in the presence of anti-rabbit serum. However, antisera against uninfected Vero cells carried a certain antibody activity in the latter two types of tests. This antibody activity was characterized by pronounced prozone phenomena and was readily removed by absorption with uninfected Vero cells. Antisera against Newcastle disease virus in Vero cells which contained high titers of homologous antibodies did not carry any detectable antibody activity in measles virus HI and HLI tests even in the presence of anti-rabbit serum.
DISCUSSION
Measles virus is a member of the paramyxovirus group. However, it displays certain distinguishing characteristics, e.g., the absence of any detectable neuraminidase (4). Somewhat surprisingly it has been found that in paramyxoviruses exhibiting neuraminidase activity this is carried by the same glycopeptide as the hemagglutinin activity (21) . In addition to this glycopeptide, the envelope of paramyxoviruses contains a smaller glycopeptide (6) . Similarly, two glycoproteins, the larger of which carries hemagglutinating activity, has also been identified in measles virus particles (3) . From further studies of Sendai virus (20) it has been proposed that the smaller glycoprotein of paramyxoviruses is involved in virus-induced hemolysis, cell fusion, and penetration of virus into cells. On the basis of the effect of certain carbobenzoxy tripeptides, it was proposed that these three biological activities might represent dif-ferent expressions of one of the biologically active components also in measles virus (10 (3) . In the present study, low concentrations of trypsin were employed since it was found in previous studies that the measles virus hemagglutinin and the receptors on erythrocytes are highly sensitive to the action of this enzyme (8) . Taking advantage of this dual effect of trypsin, an efficient technique for obtaining a high degree of purification of projection-less virus particles and free projections was developed. By electron microscopy, the trypsin-treated particles still contained a few detectable projections. It is possible that these may represent the structures responsible for the production of HLI antibodies in rabbits immunized with purified projection-less virus particles. However, it is equally possible that other structures may be involved and it should be emphasized that no information is available as concerns the relative amount of the original concentration of hemolysin which remains in the virus envelope after the treatment. It is of interest that a similar difference in relative susceptibility of hemagglutinin and neuraminidase surface projections of influenza virus to treatment with protolytic enzymes was recently observed (N. G. Wrigley, personal communication).
A possible importance of antibodies against normal cellular constituents in hyperimmune sera needs evaluation when sensitizing antibodies are identified in HLI and neutralization tests. It was found that antibodies against noninfected cells display activities in these tests, but by use of absorption experiments it could be excluded that antibodies of this kind were responsible for the sensitizing antibody activity of rabbit hyperimmndne sera against different purified virus products.
A possible significance of measles HLI antibodies in vivo for protection against the disease should be further analyzed. This may be of particular interest with regard to the evaluation of the relatively poor protecting capacity of hitherto used inactivated measles vaccines (9, 13, 14) . Two types of inactivated measles virus vaccines have been tested. One is a formalininactivated vaccine and the other a purified hemagglutinin product prepared from TEtreated material. Both these vaccines induced good amounts of neutralizing and HI antibodies. However, it was experienced that these antibodies do not provide satisfactory protection upon exposure to wild virus. About 50 to 100 times more antibodies induced by killed vaccines as compared to neutralizing and HI antibodies supplied in the form of passive immunization with gamma globulin were needed to give a corresponding degree of protection. Further, exposure to wild virus or to vaccine virus in certain cases caused aberrant reactions interpreted to represent Arthus phenomena. One way of explaining this situation would be to assume that the inactivated vaccines employed have been defective with regard to a certain antigen quality. The hemolysin of the virus might be the crucial component in this context, since both types of treatments used for preparing inactivated vaccines appear to have destroyed this component. As shown here, rabbit hyperimmune sera against TE-and formalin-killed products absorbed with TEtreated antigen did not contain any antibodies with HLI and neutralizing activity detectable in the absence or presence of anti-antiserum. Further studies by use of serological techniques presented in this publication have shown that neither of the two types of killed measles virus vaccines are capable of inducing HLI antibody production in humans (E. Norrby et al., manuscript in preparation).
